deoxyribose has been researched along with decitabine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babilonia, G; Bedell, V; Clark, J; Lamparska, K; Smith, SS; Yip, W | 1 |
1 other study(ies) available for deoxyribose and decitabine
Article | Year |
---|---|
2'-Deoxyriboguanylurea, the primary breakdown product of 5-aza-2'-deoxyribocytidine, is a mutagen, an epimutagen, an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile sites.
Topics: Azacitidine; Base Sequence; Cell Line, Tumor; Chromosome Fragile Sites; Decitabine; Deoxyribose; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Modification Methylases; DNA-Cytosine Methylases; Enzyme Inhibitors; Guanidines; Humans; Molecular Sequence Data; Mutagenesis; Mutagens; Oligodeoxyribonucleotides | 2012 |